NASDAQ · Drug Manufacturers - Specialty & Generic

TLPH (TLPH) Stock

$1.26 -6.67% NASDAQ: TLPH Healthcare

Valuation

MetricValue
Price$1.26
Market Cap$25.85M
P/E Ratio-3.31
P/B Ratio2.59
P/S Ratio18311.08
EPS (TTM)$-0.28
52-Week High$1.57
52-Week Low$0.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-118.40%
ROA-40.19%
ROCE-76.47%
Gross Margin100.00%
Operating Margin-14516.00%
Net Margin-14253.00%
Debt/Equity0.35
Current Ratio5.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$1.0M$0$0
Operating Profit$-18.0M$-20.0M$-17.0M$-15.0M$-13.0M
Net Profit$-35.0M$43.0M$-18.0M$-13.0M$-14.0M
EPS$-5.86$5.72$-1.29$-0.50$-0.34
Op Margin-4792.6%—-2594.3%—-48157.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$78.0M$47.0M$20.0M$18.0M$30.0M
Total Liabilities$114.0M$26.0M$6.0M$10.0M$13.0M
Cash$8.0M$15.0M$6.0M$9.0M$6.0M
Borrowings$19.0M$10.0M$0$7.0M$6.0M

Latest News

Talphera, Inc. Q1 2026 Earnings Call Summary Moby · May 14, 2026 Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEFRO Study Progress Amid Rising ... GuruFocus.com · May 14, 2026 Talphera Q1 2026 Earnings Call Transcript Benzinga · May 13, 2026 Talphera (TLPH) Q1 2026 Earnings Transcript Motley Fool · May 13, 2026 Talphera: Q1 Earnings Snapshot Associated Press · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-30.0M$-28.0M$-17.0M$-13.0M$-11.0M
Investing Cash Flow$-28.0M$36.0M$-1.0M$4.0M$-14.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-15.0M$8.0M$-15.0M$3.0M$-3.0M
Free Cash Flow$-32.0M$-29.0M$-18.0M$-13.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-61.68%
Quick Ratio5.30
Interest Coverage—
Return 1Y229.57%
Return 3Y19.84%
Return 5Y-94.25%

Ownership

Insiders Held21.42%
Institutions Held34.76%
Institutions Float Held44.23%
Institutional HolderSharesReport Date
AIGH Capital Management LLC4,661,5022026-03-31
Rock Springs Capital Management, LP3,589,1862026-03-31
Nantahala Capital Management, LLC3,492,5192026-03-31
Rosalind Advisors, Inc.3,353,9162026-03-31
Bleichroeder LP1,307,7872026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APUS $5.15 +4.67% -7.51 $7.77M 0.00%
COSM $0.21 +3.75% -0.44 $12.88M 0.00%
IBIO $1.45 +1.40% -0.91 $22.89M 0.00%
INTS $4.57 +2.70% -0.60 $12.35M 0.00%
ITRMIterum Therapeutics plc $0.03 -10.98% -0.06 $1.60M 0.00%

About TLPH

TLPH is led by CEO Vincent J. Angotti, employs 13 people, headquartered in US, publicly traded since 2011.

TLPH stock trades at $1.26 with a market capitalization of $25.85M. The stock is valued at a price-to-earnings (P/E) ratio of -3.31, price-to-book of 2.59, price-to-sales of 18311.08. Over the past 52 weeks the stock has ranged between $0.38 and $1.57, and currently trades 19.7% below its 52-week high.

On profitability, TLPH generates a return on equity (ROE) of -118.40%, return on capital employed of -76.47%, an operating margin of -14516.00%, a net profit margin of -14253.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides